Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
30 Novembre 2023 - 10:47AM
Capital Increase in Bavarian Nordic A/S as a Result of Employee
Warrant Exercise
COPENHAGEN, Denmark, November 30,
2023 – Bavarian Nordic A/S (OMX: BAVA) announced today
that the Company's share capital has been increased by nominally
DKK 1,692,300 as a consequence of employees’ exercise of
warrants.
The capital increase was effected without any
pre-emption rights for the existing shareholders of the Company or
others. The shares were subscribed for in cash at the following
prices per share of nominally DKK 10: 163,101 shares at DKK 142.00
and 6,129 shares at DKK 146.60. The total proceeds to Bavarian
Nordic A/S from the capital increase amounts to DKK 24 million.
The new shares, which will rank pari passu in
all respects with existing Bavarian Nordic shares, will be admitted
to trading and official listing on Nasdaq Copenhagen as soon as
possible.
After the capital increase, the total nominal
value of Bavarian Nordic A/S' share capital is DKK 780,978,340,
which is made up of 78,097,834 shares of a nominal value of DKK 10
each, corresponding to 78,097,834 votes.
The revised Articles of Association will be
published shortly on the Company's website.
The content of this announcement does not affect
the Company’s expectations for the financial results for 2023.
About Bavarian Nordic Bavarian
Nordic is a fully integrated vaccine company with a mission to
protect and save lives through innovative vaccines. We are a global
leader in smallpox and mpox vaccines, supplied to governments to
enhance public health preparedness and have a strong portfolio of
vaccines for travelers and endemic diseases. For more information
visit www.bavarian-nordic.com.
Forward-looking statements This
announcement includes forward-looking statements that involve
risks, uncertainties and other factors, many of which are outside
of our control, that could cause actual results to differ
materially from the results discussed in the forward-looking
statements. Forward-looking statements include statements
concerning our plans, objectives, goals, future events, performance
and/or other information that is not historical information. All
such forward-looking statements are expressly qualified by these
cautionary statements and any other cautionary statements which may
accompany the forward-looking statements. We undertake no
obligation to publicly update or revise forward-looking statements
to reflect subsequent events or circumstances after the date made,
except as required by law.
ContactsEurope: Rolf Sass
Sørensen, Vice President Investor Relations, Tel: +45 61 77 47
43US: Graham Morrell, Paddock Circle Advisors,
graham@paddockcircle.com, Tel: +1 781 686 9600
Company Announcement no. 37 / 2023
Bavarian Nordic AS (TG:BV3)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Bavarian Nordic AS (TG:BV3)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024